1. Zhou J, Ran J, He ZY, et al. Tailoring pelvic lymphadenectomy for patients with stage IA2, IB1, and IIA1 uterine cervical cancer. GynecolOncol. 2010;119(2):187–91.
2. Kim MK, Kim JW, Kim MA, et al. Feasibility of less radical surgery for superficially invasive carcinoma of the cervix. GynecolOncol. 2010;119(2):187–91.
3. Gray HJ. Primary management of early stage cervical cancer (IA1-IB) and appropriate selection of adjuvant therapy. J NatlCompr Cancer Netw. 2008;6:47–52.
4. Salicrú SR, de la Torre JF, Gil-Moreno A. The surgical management of early-stage cervical cancer. CurrOpinObstetGynecol. 2013;25(4):312–9.
5. Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. GynecolOncol. 2006;103:714–8.